Driven by the escalating prevalence of dry eye syndrome (DES), increasing digital screen exposure across all age groups, expanding elderly populations susceptible to ocular hypertension, and innovations in preservative-free, long-acting formulations, the global ophthalmic drugs and topical eye care sector is experiencing strong momentum. According to market research and strategic intelligence...